Recent News for MYL - Mylan Inc.

Date Title
May 22 Use of malaria drugs in COVID-19 carries higher mortality risk - study
May 22 Top Research Reports for Intel, Adobe & AMD
May 19 Delaware Enhanced Global Dividend and Income Fund Appoints Allan Saustrup Jensen as Co-Manager
May 19 In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs
May 18 Pfizer Inc. -- Moody's assigns A1 to Pfizer's notes; on review for downgrade
May 17 Better Buy: Pfizer vs. Bristol Myers Squibb
May 14 Markets Set Out on Long Journey to Recovery: 4 ROE Picks
May 13 Coronavirus update: Global case tally tops 4.28 million as Russia sees spike in cases, Brazil and Mexico suffer deadliest day yet
May 13 Mylan to Present at the 2020 RBC Capital Markets' Virtual Global Healthcare Conference
May 13 US STOCKS-Futures climb ahead of Fed Chair Powell's address
May 13 The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
May 12 Gilead Strikes Deal With Mylan to Supply Remdesivir Internationally
May 12 Mylan to Supply Investigational Antiviral Remdesivir for the Potential Treatment of COVID-19
May 12 Gilead announces non-U.S. deals with five generic drugmakers for remdesivir
May 12 Gilead inks deals to sell remdesivir in 127 countries
May 12 Is Mylan (MYL) Stock Undervalued Right Now?
May 12 Edited Transcript of MYL earnings conference call or presentation 11-May-20 2:30pm GMT
May 12 Mylan N.V. (MYL) CEO Heather M. Bresch on Q1 2020 Results - Earnings Call Transcript
May 11 Mylan N.V. (MYL) Q1 2020 Earnings Call Transcript
May 11 What's Behind Mylan's Mixed Q1 Results
May 11 Mylan (MYL) Beats on Q1 Earnings on Coronavirus-Led Stockpiling
May 11 Mylan N.V. 2020 Q1 - Results - Earnings Call Presentation
May 11 Drug Stockpiling Lends Generic Pharma Stock A Boost — But Not Enough
May 11 Mylan (MYL) Q1 Earnings Top Estimates
May 11 Mylan Swings to Profit as Drug Sales Jump

Back to the Main MYL Page...